Pharmacokinetics of Cefamandole in Infants and Children
AUTOR(ES)
Walker, Stuart H.
RESUMO
In infants less than 3 months of age, the serum concentration of cefamandole during therapy was higher and more prolonged than that in children older than 1 year. A dosage of 37 mg/kg administered intravenously at 6-h intervals provided a serum concentration in excess of the minimum inhibitory concentrations of common bacterial pathogens for 4 h, and in young infants for 5 h, after dosing.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=352456Documentos Relacionados
- Pharmacokinetics and Safety of Cefamandole in Infants and Children
- Pharmacokinetics and Safety of Cefamandole in Newborn Infants
- Pharmacokinetics of cefprozil in infants and children.
- Pharmacokinetics of Gatifloxacin in Infants and Children
- Clinical and Laboratory Investigation of Cefamandole in Infections of Infants and Children
